# Effects of the Direct Interaction Between Streptococcus Salivarius 24SMBc and Streptococcus Oralis 89a and the Respiratory Epithelium in Children

> **NCT03449836** · PHASE3 · UNKNOWN · sponsor: **Federico II University** · enrollment: 60 (estimated)

## Conditions studied

- Allergy

## Interventions

- **COMBINATION_PRODUCT:** Streptococcus salivarius 24SMBc + Strept. oralis 89a
- **COMBINATION_PRODUCT:** fluticasone + mometasone
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT03449836
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-01
- **Primary completion:** 2018-09-30
- **Final completion:** 2018-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2018-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03449836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03449836, "Effects of the Direct Interaction Between Streptococcus Salivarius 24SMBc and Streptococcus Oralis 89a and the Respiratory Epithelium in Children". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03449836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*